flanmnatory factors or upon stimulation with glucocorticoids. Once released, MIF "overrides" or counterregulates the immunosuppressive effects of steroids on cytokine production and immune cellular activation. To further investigate the biology of MIF and its role in the neuroendocrine system, we have studied the regional and cellular expression of MIF in brain tissue obtained from normal rats and rats administered LPS intracisternally. Materials and Methods: Rat brain sections were analyzed by immunohistochemistry utilizing an affinity-purified, anti-MIF antibody raised to recombinant MIF, and by in situ hybridization using a digoxigenin-labeled, antisense MIF cRNA probe. The kinetics of MIF mRNA expression in brain were compared with that of IL-1, IL-6, and TNF-a by RT-PCR of total brain RNA. The cerebrospinal fluid content of MIF and TNF-a proteins was analyzed by Western blotting and ELISA. Results: A strong baseline expression pattern for MIF was observed in neurons of the cortex, hypothalamus, hippocampus, cerebellum, and pons. By in situ hybridization, MIF mRNA was found predominantly in cell bodies whereas MIF protein was detected mostly within the terminal fields associated with neurons. There was a marked pattern of MIF immunoreactivity within the mossy fibers of the dentate gyrus and dendrites of the hippocampal CA3 field. These structures have been shown previously to be involved in glucocorticoid-induced tissue damage within the hippocampus, suggesting an association between MI; and targets of glucocorticoid action. The intracistemal injection of LPS increased MIF mRNA and protein expression in brain and MIF immunoreactivity was due in part to infiltrating monocytes/macrophages. MIW protein also was found to be rapidly released into the cerebrospinal fluid. This response corresponded with that of LPS-induced cytokine release and MIF mRNA expression increased in a distribution that colocalized in large part with that of TNF-a,
Introduction
The protein mediator known as macrophage migration inhibitory factor (MIF) was one of the first cytokine activities to be discovered and was described 30 years ago as a T cell-derived factor that inhibited the random migration of macrophages (1) (2) (3) . More recent studies have led to the description of a pituitary mediator that appears to act as an endogenous, counterregulatory hormone for glucocorticoid action within the immune system. Isolated as a product of an anterior pituitary cell line, this protein was sequenced and found to be the mouse homolog of MIF (4) . Subsequent work showed that macrophages and T cells secrete MIF in response to glucocorticoids and activation by proinflammatory stimuli (5, 6) . Once (4, 6) . Immunogold electron microscopy studies have shown that MIF is secreted from the same pituitary cell granules as those containing adrenocorticotropic hormone (ACTH) and thyroidstimulating hormone (TSH) (7) . MIF transcripts and protein are also expressed in the aldosterone-and glucocorticoid-producing epithelial cells of the adrenal cortex (8) , the testosterone-producing Leydig cells of the testes (9) , and the insulin-secreting ,B cells of the pancreas (10) . Furthermore, the isolation of MIF protein has been reported recently from whole bovine brain cytosol (1 1 
Surgery
In-dwelling cannulae were preassembled, sterilized prior to surgery, and implanted using strict aseptic technique at Zivic-Miller Laboratories. All rats were anesthetized in a chamber supplied with a 2.5% mixture of halothane and oxygen for approximately [3] [4] [5] min, or until the proper surgical plane of anesthesia was attained. The rats then were placed on a stereotactic frame equipped with an anesthesia mask. A 1.5-cm mid-sagittal skin incision was made on the scalp to expose the skull, and the exposed area was vigorously wiped with a fresh cotton applicator to remove connective tissue. This skull was then dried and the lambda was identified. With the use of a dental drill and a No. 2 dental burr, one hole was carefully drilled through the skull at approximately 2 mm posterior and 2 mm lateral to lambda. One #0-80 stainless steel machine screw was carefully inserted so that it was seated above the dura. The incisor bar of the stereotactic frame was adjusted so that the animal's head pointed down. A small scrapper was then used to remove any muscle fibers from their point of insertion on the nuchal crest. Another hole was drilled on the midline of the nuchal crest, creating an opening between the cerebellum and the occipital squama. A sterile 28-gauge hypodermic needle was filled with artificial CSF (Harvard Apparatus, South Natick, MA) and the tip of the needle was inserted into the opening and ad-vanced to a predetermined length for tip placement in the cisterna magnum. Cyanoacrylate glue was used to immobilize the cannula and seal the opening. The needle was attached to the skull by means of dental acrylic and was plugged with PE 20 tubing that had been heat sealed. The dental cement was allowed to harden for approximately 5 min, and the animal was released from the stereotactic frame. The rats were then injected with antibiotic and placed in a heated recovery cage. As the rats regained their righting reflex, they were removed from the heated recovery cage and housed in individual cages in an animal holding room. All procedures were in compliance with the standards recommended by the "Guide for the Care (19) . Each primer pair yielded the predicted size of the amplified DNA product. Frozen tissues were ground in RNAzol-B (Tel-Test Inc., Friendswood, TX) using a polytron (Littau, Switzerland) tissue homogenizer. cDNA was prepared from 0.5-1.0 ,g of total RNA using 0.25 ng of oligo-(dT) [12] [13] [14] [15] [16] [17] [18] and Superscript II following the manufacturer's protocol (Gibco BRL, Gaithersburg, MD). Two-microliter aliquots of cDNA then were amplified by PCR in a Perkin-Elmer model 9600 thermal cycler using the primers listed above and the following cycling program: denaturation for 1 min at 95°C, annealing for 10 sec at 550-650C, and extension for 20 sec at 720C.
CSF Analysis for MIF and TNF-a CSF samples were obtained at baseline and 3, 6, and 24 hr after the intracisternal injection of LPS. MIF content was analyzed by Western blotting using polyclonal antibodies against murine rMIF (20) . Rat TNF-a was analyzed by ELISA using a commercially available kit and following the manufacturer's protocol (Genzyme, Cambridge, MA). All samples were run in triplicate.
Results
Localization of MIF mRNA in Rat Brain To examine first the regional and cellular localization of MIF mRNA in rat brain, sagittal sections of adult brain tissue were hybridized with a digoxigenin-labeled, antisense MIF cRNA probe. As a control, sections were also hybridized under the same conditions with a digoxigenin-labeled, sense cRNA probe. An excellent signal-to-noise ratio was obtained by this method and cell bodies hybridizing to the MIF antisense probe were detected in each of the sagittal sections that were analyzed. The most intense hybridization signals appeared to be located predominantly within neurons. Strong signals were present in the supragranular part of the cerebral cortex (Fig. 1A and C), in pyramidal neurons (regions CA1-3), in granule cells of the dentate gyrus within the hippocampus (Fig. IE) , in Purkinje cells and granular cells of the cerebellum ( Fig. 2A and C) , within the dorsomedial and ventromedial nuclei of the hypothalamus (Fig. 2E) , in the pons (Fig. 3A) , and within the plexiform and granular layer of the olfactory bulb (Fig. 3E) . In the hippocampus, the cell bodies of the pyramidal cells in the CA1 to CA3 region and the granule cells of the dentate gyrus were strongly labeled, whereas the white matter showed no detectable hybridization signals (Fig. 1E ). In the cerebellar cortex, a few homogeneously distributed cells within the molecular layer hybridized to the MIF probe. By contrast, intense hybridization was found in the granular layer and most prominently in the Purkinje cells ( Fig. 2A and C) . A much less intense but more homogenous pattern of MIF mRNA hybridization was also observed diffusely in different regions of the brain, suggesting that glial cells also express MIF in detectable levels. The specificity of the MIF hybridization signals was confirmed by performing control studies with an MIF sense cRNA probe, which demonstrated only very low levels of background staining (Fig. 4) (Fig. 5) .
In contrast to the distinct appearance of MIF mRNA within the cell bodies of neurons, immunoreactive MIF protein was detected predominantly in axons. In the cerebral cortex, positive immunostaining for MIF was strongest in neuronal fibers and as a homogenous, interstitial band in the supragranular layer ( Fig. 1B and ID) . At higher power, MIF protein was detected in a few dispersed cells within this same area (Fig. i1D) . MIF-positive neuronal projections and terminals were observed in the hippocampus (Fig. IF) , in the hilus of the dentate gyrus and, more strongly, within the stratum lucidum in close association with the apical dendrites of pyramidal cells and the mossy fiber terminals of granule cells. A similar pattern of MIF protein immunostaining has been described recently in a study of bovine brain hippocampus (22) .
A further region of intense immunoreactivity was found in the cerebellar cortex ( Fig. 28  and D) , most prominently in the fibers associated with Purkinje cells. Staining was less pronounced in the granular cell layer. Within the hypothalamus, the strongest staining for MIF was in the terminal fields in the ventromedial and dorsomedial nuclei. Numerous scattered cell bodies were also found to be labeled in the hypothalamus, and the homogenous pattern of staining was due most likely to glial cells. Intense immunostaining also was evident in the axonal fiber tracts of the pons (Fig. 3B) , and in a few dispersed cells.
Of all regions of the brain examined, the most intense level of MIF immunostaining was in the epithelial cells of the choroid plexus (Fig. 3D) . Interestingly, these cells contained no detectable MIF transcripts (Fig. 3C ), suggesting that they may be involved in the uptake of MIF from the CSF.
MIF Expression after Intracisternal Endotoxin (LPS) Injection
Prior studies have identified MIF as playing a critical role in the host response to endotoxic 4 . Control studies examining the in situ hybridation of the MIF sense cRNA probe. Sections of cortex (A) (X400), cerebellum (B) (Xo00), and hippocampus (C) (X 100) are shown.
was undetectable until 34 cycles, indicating that under normal conditions the mRNA for MIF is present in much more abundant quantities than these other mRNAs. This finding was confirmed by Northern hybridization in which brain RNA was sequentially hybridized with TNF-a, IL-1X3, IL-6, and MIF probes. A very strong signal for MIF was observed after less than 4 hr of exposure of the Northern blot to autoradiographic film. By contrast, no signals were evident for the mRNA of the other cytokines, even after a 48-hr exposure (data not shown).
MIF mRNA levels in brain increased after intracerebroventricular LPS administration, and reached a maximum level of induction 6 hr after endotoxin injection (Fig. 6) . The mRNAs for IL-1,B, IL-6, and TNF-a were detectable only after 3 hr, reached peak levels at 6 hr, and then decreased at 24 hr.
Intracerebroventricular LPS injection was also associated with the appearance of strongly positive MIF cells by immunohistochemistry (Fig. 7) . MIF-labeled cells were found in the cortex (Fig. 7B ) and in the hypothalamus (data not shown) within 6 hr of LPS administration, and their number increased at 24 hr (Fig. 7B, C) . Staining of serial sections for the cell surface marker CD68 (ED-1) (Fig. 7G-I ) revealed a portion of the MIF-positive cells to be of monocyte/ macrophage origin and to be associated with blood vessel walls (Fig. 7D-F (Fig. 8 ), we observed a sharp peak of MIF immunoreactivity after 3 hr of LPS injection. The magnitude of the inflammatory response correlated with the induction of TNF-a. In a group of five tested animals, the lowest and the highest levels of MIF induction were accompanied by a corresponding pattern of TNF-a expression (Fig. 8 ).
Discussion
We have examined the complete regional and cellular distribution of MIF mRNA and protein in the adult rat brain. The high abundance of MIF mRNA and protein that is associated with different neurons suggests a requirement for this protein in aspects of CNS physiology that include autonomic, hypophysiotrophic, limbic, and extrapyramidal functions. The occurrence of MIF within the hypothalamus also complements prior studies identifying MIF as an important molecular constituent of the HPA axis. MIF is released by stress from the corticotrophic cells of the anterior pituitary gland (20, 7) , and it also is present preformed within the zona glomerulosa of the adrenal gland. Both the pituitary and the adrenals secrete MIF in the course of a systemic inflammatory response induced by endotoxemia (7, 8) .
Within the immune system, MIF is secreted both by macrophages and T cells in response to glucocorticoid stimulation (6, 23 (24) (25) (26) (27) . MIF thus may act to directly regulate this toxic effect of glucocorticoids on the hippocampus. Glucocorticoids have also been shown to act synergistically with various excitatory amino acids (28, 29) . Mossy fibers originating from the granule cells of the dentate gyrus provide a strong input of excitatory amino acids into the hippocampal CA3 region (30) . MIF immunoreactivity was associated with mossy fibers, as well as with the dendritic branches of the hippocampal CA3 field, a second area that has been described to suffer from glucocorticoid-induced atrophy (26, 27) .
Although a precise functional relationship between MIF and glucocorticoid action in the brain remains to be experimentally established, it should be noted that there are also recent data linking MIF expression with the local regulation of various endocrine tissues. In the testes, Leydig cell MIF production has been found to regulate inhibin secretion by Sertoli cells (9) , and within We found that there was a significant discrepancy between the expression of MIF mRNA and protein in the olfactory bulb. A strong hybridization signal for MIF mRNA was evident but no MIF immunoreactivity could be detected. Possible explanations for this result might be a fast axonal transport and release of MIF, or that MIF might bind to a locally produced factor in the olfactory bulb which abolishes antibody recognition.
Outside of neurons and their processes, MIF mRNA and proteins were also detected diffusely throughout the brain, suggesting that glial cells were also a source of MIF expression. This complements the recent identification of MIF as an important secretory component of monocytes and tissue macrophages (5, 8) .
(C, F) after LPS injection. Immunostaining for ED 1-positive monocytes in the cortex (G, H) and blood vessels (I) in untreated rats (G), and 24 hr after LPS administration (H, I) (X400).
We also examined the effect of intracisternal LPS administration on MIF mRNA and protein expression. It is worth noting that the regional and cellular distribution of MIF at baseline showed certain similarities with what has been described previously for the cytokines IL-IO and IL-6. (3 1-35) . The mRNAs for IL-1 3 and IL-6 are also present in the cell bodies of hippocampal and cerebellar neurons, and immunoreactive IL-1,3 can be detected within the neuronal processes and terminals of pyramidal and granular cells within the hippocampus. Infiltrating monocytes, in part associated with the walls of blood vessels, are another source of LPS-induced MIF and cytokine production in the CNS. As expected, intracisternal LPS injection was associated with a significant increase in the expression of mRNAs encoding MIF, IL-113, IL-6, and TNF-a (36, 37 kines. However, the most striking difference between MIF and the cytokines IL-1,B, IL-6, and TNF-a was in the magnitude of the mRNA expression level at baseline. MIF transcripts were readily detected after 21 cycles of DNA amplification, whereas the mRNAs for the other cytokines were not detectable until 34 cycles. From our experience with these primer sequences, this result implies at least a 4-log difference in baseline expression levels. These data are also consistent with results obtained by Northern blotting analysis of whole rat brains (M. Bacher et al., unpublished observations). Intracisternal LPS administration was also associated with the appearance of MIF protein in the CSF. The increase in MIF in this compartment was due most likely to MIF release from the epithelial cells of the choroid plexus. At baseline, these cells showed the strongest immunoreactivity for MIF among the brain structures that were examined. Interestingly, the choroid plexus showed very little MIF mRNA by in situ hybridization, suggesting that this tissue plays a role in the uptake or transport of MIF. LPS, either directly or via secondary mediators, may then induce the release of MIF from the epithelial cell pool. The magnitude of MIF release into the CSF also correlated with the magnitude of the LPS-induced TNF-a response.
Recent studies have identified MIF as both an anterior pituitary hormone and an immune cell "cytokine" released in response to glucocorticoid stimulation. Within the immune system, MIF functions to "override" or counterregulate glucocorticoid inhibition of inflammatory cytokine production. The present data in rat brain establish that MIF is present constitutively within both glial and neuronal cell types, and that the CNS expression of MIF is regulated by inflammatory stimuli such as LPS. MIF may function as a neuromodulator, neurotransmitter, or neurotrophic factor, and it may be associated with glucocorticoid action within the CNS. The high levels of baseline and inducible MIF expression in the brain nevertheless underscore its role as a neuroendocrine mediator and extend the importance of MIF as a physiological regulator of the inflammatory stress response.
